{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:42:35Z","timestamp":1759405355934,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vaccine.2023.02.039","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T15:57:42Z","timestamp":1676649462000},"page":"1979-1988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent)"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1528-3296","authenticated-orcid":false,"given":"Dnyanesh","family":"Ranade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9274-2682","authenticated-orcid":false,"given":"Rajender","family":"Jena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kundan","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Dogar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubham","family":"Sancheti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"Deore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharam","family":"Ashtagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4093-9736","authenticated-orcid":false,"given":"Sunil","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.02.039_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585354","article-title":"A review of the progress and challenges of developing a vaccine for COVID-19","volume":"11","author":"Sharma","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.02.039_b0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1099\/jmm.0.039180-0","article-title":"The current challenges for vaccine development","volume":"61","author":"Oyston","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2023.02.039_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1208\/s12248-011-9261-1","article-title":"A rational, systematic approach for the development of vaccine formulations","volume":"13","author":"Morefield","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.vaccine.2023.02.039_b0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/14760584.2017.1322512","article-title":"Pre-clinical and clinical development of the first placental malaria vaccine","volume":"16","author":"Pehrson","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.02.039_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/IAI.01106-12","article-title":"Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria","volume":"81","author":"Fried","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.02.039_b0030","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(21)01065-5","article-title":"R21\/Matrix-M: a second malaria vaccine?","volume":"397","author":"Moorthy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.02.039_b0035","first-page":"726","article-title":"Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries","volume":"81","author":"Drain","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2023.02.039_b0040","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1016\/j.vaccine.2010.05.048","article-title":"Single versus multi-dose vaccine vials: an economic computational model","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.039_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1885278","article-title":"Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries","author":"Basu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.02.039_b0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0140-6736(21)02754-9","article-title":"Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil","volume":"399","author":"Katikireddi","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.02.039_b0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00103-019-03062-1","article-title":"National immunization programmes","volume":"63","author":"Cherian","year":"2020","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.vaccine.2023.02.039_b0060","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1016\/j.vaccine.2010.07.009","article-title":"Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults","volume":"28","author":"Lin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.039_b0065","unstructured":"WHO. WHO Policy Statement: Multi-dose Vial Policy (MDVP); 2014."},{"key":"10.1016\/j.vaccine.2023.02.039_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200115001-00001","article-title":"A recently developed typhoid Vi polysaccharide vaccine","volume":"15","author":"Zuckerman","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2023.02.039_b0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1590\/S0074-02762010000100013","article-title":"Comparative evaluation of phenol and thimerosal as preservatives for a candidate vaccine against American cutaneous leishmaniasis","volume":"105","author":"Mayrink","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.039_b0080","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/jps.20976","article-title":"Antimicrobial preservative use in parenteral products: past and present","volume":"96","author":"Meyer","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2023.02.039_b0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijbiomac.2020.03.156","article-title":"Toxicity of thimerosal in biological systems: conformational changes in human hemoglobin, decrease of oxygen binding capacity, increase of protein glycation and amyloid's formation","volume":"154","author":"de Magalh\u00e3es","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2023.02.039_b0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s40521-022-00311-8","article-title":"Adverse reactions to anti-infective vaccines: an emerging problem in the COVID-19 era","volume":"9","author":"Escudero","year":"2022","journal-title":"Curr Treat Opt Allergy"},{"key":"10.1016\/j.vaccine.2023.02.039_b0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0377-1237(07)80067-0","article-title":"Combination vaccines","volume":"63","author":"Jatana","year":"2007","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.vaccine.2023.02.039_b0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1472-765X.1994.tb00820.x","article-title":"The antimicrobial activity of phenoxyethanol in vaccines","volume":"18","author":"Lowe","year":"1994","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.vaccine.2023.02.039_b0105","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1016\/j.vaccine.2011.05.074","article-title":"Preservative of choice for Prev(e)nar 13\u2122 in a multi-dose formulation","volume":"29","author":"Khandke","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.039_b0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1365\/s10337-003-0127-2","article-title":"Validation of HPLC analysis of 2-phenoxyethanol, 1-phenoxypropan-2-ol, methyl, ethyl, propyl, butyl and benzyl 4-hydroxybenzoate (parabens) in cosmetic products, with emphasis on decision limit and detection capability","volume":"59","author":"Borremans","year":"2004","journal-title":"Chromatographia"},{"key":"10.1016\/j.vaccine.2023.02.039_b0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biologicals.2007.05.005","article-title":"A simple and rapid method for quantifying 2-phenoxyethanol (2-PE) in Diphtheria, Tetanus and w-Pertussis (DTwP) vaccine","volume":"36","author":"Sharma","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2023.02.039_b0120","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.02.039_b0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.vaccine.2021.12.019","article-title":"Rapid, high throughput protein estimation method for saponin and alhydrogel adjuvanted R21 VLP Malaria vaccine based on intrinsic fluorescence","volume":"40","author":"Ranade","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.039_b0130","unstructured":"Agency EM. ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology; 1995."},{"key":"10.1016\/j.vaccine.2023.02.039_b0135","first-page":"51","author":"Gomez","year":"2018","journal-title":"Vaccine Manufacturing: Plotkin's Vaccines"},{"key":"10.1016\/j.vaccine.2023.02.039_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jdv.15944","article-title":"Safety review of phenoxyethanol when used as a preservative in cosmetics","volume":"33","author":"Dr\u00e9no","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.vaccine.2023.02.039_b0145","unstructured":"Pharmacopeia U. USP <1225> Validation of Compendial methods."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:21Z","timestamp":1759404321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0264410X23001743"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}